OpGen, Inc. OPGN
Set alert
23.91 USD 0.00 0.00%
As of Mar 19, 9:30 AM ET
23.91 Day range 23.91
1.75 52-week range 34.00
- YTD
- +50.38%
- 1 year
- +386.97%
- Open
- 23.91
- Prev close
- 23.91
- Mkt cap
- 242.67M
- Vol
- 1.28K
- Avg vol
- 157
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 23.91
- High
- 23.91
- Forward P/E
- -6.93
- Beta
- -0.66
- Short ratio
- 1.23
- Inst. own
- 0.06%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Apr 3, 2024
- 50-d avg
- 2.46
- 200-d avg
- 3.84
- 1y target
- 0.00
6M chart
Signals (16)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Mar 17, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| RSI: Oversold | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Feb 20, 2026 | 8 months ago |
| RSI: Overbought | Feb 17, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 4, 2026 | 9 months ago |
| RSI: Overbought | Feb 4, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 15, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 13, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 12, 2026 | 9 months ago |
| RSI: Overbought | Dec 23, 2025 | 10 months ago |
| RSI: Overbought | Dec 17, 2025 | 10 months ago |
| RSI: Overbought | Nov 26, 2025 | 11 months ago |
| SMA: Bullish | Nov 3, 2025 | 12 months ago |
| RSI: Overbought | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Oct 28, 2025 | 1 year ago |
Key statistics
- Market cap
- 16.79M
- Enterprise value
- 31.42M
- Trailing P/E
- 0.00
- Forward P/E
- -6.93
- PEG ratio
- 0.00
- Price / sales
- 8.55
- Price / book
- 0.00
- EPS (TTM)
- -40.32
- Beta
- -0.66
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 1.96M
- Revenue growth
- -96.20%
- Free cash flow
- -2.87M
- Total cash
- 168.11K
- Total debt
- 13.20M
- Return on equity
- 0.00%
- Shares outstanding
- 8.36M
- Short % of float
- 1.79%
- 50-day average
- 2.46
- 200-day average
- 3.84
Analyst view
Consensus: hold
Hold
Price target (mean) 0.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Apr 3, 2024
Expected Apr 3, 2024. Consensus EPS estimate 0.00.
Financials — quick view
OPGN Revenue — quarterly 28.00K
OPGN Net income — quarterly -1.58M
OPGN EPS — quarterly -1.18
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 15, 2024 | Sep 1, 2024 | 0.00 | 1.35 | — | — |
| Aug 19, 2024 | Jun 1, 2024 | 0.00 | -1.18 | — | — |
| Jul 8, 2024 | Mar 1, 2024 | 0.00 | 0.21 | — | — |
| Apr 3, 2024 | Dec 1, 2023 | -0.13 | — | — | — |
| Nov 14, 2023 | Sep 1, 2023 | -4.30 | -4.60 | -0.30 | -6.98% |
| Aug 10, 2023 | Jun 1, 2023 | -7.10 | -9.30 | -2.20 | -30.99% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 2023 | HC Wainwright & Co. | down | Buy | Neutral |
| Jul 19, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| Jun 25, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| Jun 20, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
| May 15, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
About OpGen, Inc.
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- opgen.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on OPGN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEN-TZVI AVRAHAM | Director | Stock Award(Grant) | Apr 10, 2024 | 100,000 |
| CROVETTO MARIO PIETRO | Director | Stock Award(Grant) | Jun 6, 2023 | 3,000 |
| ELSEY RAYMOND DON | Director | Stock Award(Grant) | Jun 6, 2023 | 3,075 |
| FERNANDES PRABHAVATHI | Director | Stock Award(Grant) | Jun 6, 2023 | 3,000 |
| LAZAR DAVID ELLIOT | Chief Executive Officer | Stock Award(Grant) | Apr 10, 2024 | 100,000 |
| MCMURDO MATTHEW CHARLES | Director | Stock Award(Grant) | Apr 10, 2024 | 100,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 7.04% | 626,175 | 510.27K | Jun 29, 2023 |
| Vanguard Group Inc | 0.41% | 36,701 | 29.91K | Jun 29, 2023 |
| Geode Capital Management, LLC | 0.20% | 18,090 | 14.74K | Jun 29, 2023 |
| Blackrock Inc. | 0.18% | 16,038 | 13.07K | Jun 29, 2023 |
| Arete Wealth Advisors, LLC | 0.17% | 15,000 | 12.22K | Jun 29, 2023 |
| Tower Research Capital LLC (TRC) | 0.09% | 8,018 | 6.53K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.41% | 36,701 | 29.91K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.11% | 9,677 | 7.27K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.03% | 2,732 | 2.05K | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.03% | 3,032 | 2.28K | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.01% | 1,305 | 980 | May 30, 2023 |